Pharmaceutical Printer of Inserts, Labels and More
Since 1928, we have been at the forefront of development in the pharmaceutical print industry. Beyond our reputation as the preeminent pharmaceutical printer, we now supply labeling and printing services for medical devices, as well as the bio-tech industry. We are committed to developing and then printing innovative materials that make it easier for you to get vital information to your customers. We do it all through a tried and tested foundation in Current Good Manufacturing Practices (CGMP) and ISO 9001:2015 standards that constantly work to achieve consistency in all of our print processes.
We are proud to boast that Pharmaceutic Litho is one of the few pharmaceutical printers with over 75,000 sq. ft. dedicated solely to pharmaceutical printing. Even so, we continue to grow and expand our secondary packaging services for the pharmaceutical and bio-tech industries in order to build on our reputation as the standard for quality and service in the pharma printing industries.
LATEST NEWS: Pharmaceutic Litho & Label Company Acquires Plymouth Printing
Wilton, CT — Pharmaceutic Litho & Label Company is excited to announce the acquisition of Plymouth Printing Company, Inc. As a current Good Manufacturing Practices (cGMP) compliant specialty printer that exclusively serves the pharmaceutical, biotech and medical device industries... continue reading
Pharmaceutical Printer Products
years in print
printed items each year
Pharmaceutical Printer News
Lonza opened the world’s largest dedicated cell and gene therapy facility, which was built in anticipation of the rising demand from developers of cell and gene therapies—believed to be the next era inRead More…
In rare cases, the lung disease COPD can be genetic. So Wednesday, on Rare Disease Day, Grifols is launching an awareness campaign to encourage COPD patients to get tested. Of the estimated 11 millionRead More…
Amgen designed a biologics manufacturing plant several years ago that was smaller, cheaper and more flexible than the traditional giant-sized, drug-specific model. Then it built it in low-cost Singapore. Now, motivated byRead More…